VOLITIONRX LTD (VNRX) Form S-3/A — Sep 8, 2026
VolitionRx Limited filed Pre-Effective Amendment No. 1 to its Form S-3 (File No. 333-298627), stating it is being made solely to update the Selling Stockholder table in the base prospectus. The registration covers 10,006,360 shares of common stock for resale by Lind Global Asset Management XII LLC, measured against 18,727,948 shares outstanding as of August 27, 2026.
Key figures
- Shares Offered
- 10006360
- Shares Outstanding
- 18727948
- Warrant exercise price
- $2.015 per share
- Original s3 filing date
- 2026-08-28
- Prior resale registrations
- 1,171,875 shares (333-288508), 850,018 shares (333-293314), 3,306,607 shares (333-297402)
- Contractual ownership limit
- 4.99% (19.99% limitation terminated March 31, 2026)
- June 2026 public offering price
- $1.55 per share
- Shares underlying 2025 lind note
- 5251150
- Shares underlying 2026 lind note
- 6182649
- Selling stockholder ownership prior
- 12,434,859 shares (4.99%)
- Shares underlying 2025 lind warrant
- 651042
- Shares underlying 2026 lind warrant
- 350018
- Market cap default principal increase
- $623,333
- Selling stockholder ownership post offering
- 2,428,499 shares (4.99%)
Price after filing
1 day: +2.9%7 days: -12.9%30 days: -32.0%
Close on the filing date to close N calendar days later (from $0.33). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.